[Clinical study on symptoms in patients with strongyloidiasis].
We treated strongyloidiasis patients and obtained the following results: Of the 299 patients (184 males and 115 females), 81 patients (27.1%) had no complaints before treatment, 218 patients complaints of some symptoms, including arthralgia and/or lumbago (28.4%), abdominal pain and/or borborygmus (19.3%), numbness of extremities (18.1%), constipation (16.3%) and itching (15.7). We treated 219 patients with mebendazole and symptoms improved after treatment described below: Thirty-seven of the 63 patients (58.7%) with arthralgia and/or lumbago improved. Twenty-seven of the 36 patients (75.0%) with numbness of extremities improved. Thirty-one of the 32 patients (96.9%) with heartburn improved. We treated 26 patients with mebendazole plus thiabendazole and twelve of 14 patients (85.7%) with abdominal pain and/or borborygmus were improved after treatment. We treated 54 patients with ivermectin and five of 18 patients (27.8%) with arthralgia and/or lumbago were improved after treatment.
Zaha
O
O
First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus.
Niimura
S
S
Kinjo
N
N
Ikema
M
M
Nakamura
H
H
Uehara
T
T
Uechi
H
H
Ohshiro
J
J
Shikiya
K
K
Kinjo
F
F
D000328:Adult; D000368:Aged; D000818:Animals; D016918:Arthritis, Reactive / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D008463:Mebendazole / Q000008:administration & dosage; D008875:Middle Aged; D017171:Strongyloides stercoralis; D013322:Strongyloidiasis / Q000150:complications / Q000188:drug therapy*; D013827:Thiabendazole / Q000008:administration & dosage
D008463:Mebendazole; D013827:Thiabendazole